Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
According to Rajat Bose of rajatkbose.com, one can buy Aurobindo Pharma, Exide Industries and Hero MotoCorp.
Sudarshan Sukhani of s2analytics.com recommends buying Aurobindo Pharma, State Bank of India and Arvind.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the market and specific stocks.
Mitessh Thakkar of mitesshthakkar.com is of the view that one may buy BEML, HCL Technologies, Titan Company and Engineers India and can sell Ramco Cements.
Ashwani Gujral of ashwanigujral.com recommends buying Dewan Housing Finance, HDFC Bank and Bajaj Finserv.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Britannia Industries and sell UltraTech Cement and Jubilant Foodworks.
Aurobindo Pharma has gotten the United States Foods and Drug Administration (USFDA) approval for a generic drug that treats a chronic kidney disease. In an interview to CNBC-TV18, Surajit Pal of Prabhudas Lilladher spoke about the same.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Britannia Industries, Colgate Palmolive, Hindustan Unilever, Hero MotoCorp, Interglobe Aviation, Lupin and Aurobindo Pharma and can sell IRB Infrastructure Developers and Housing Development and Infrastructure.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on the market and specific stocks and sectors.
Ashwani Gujral of ashwanigujral.com recommends buying Rashtriya Chemicals & Fertilizers and Sintex Industries and advises selling Escorts, IRB Infrastructure and VIP Industries.
HUL and Aurobindo Pharma are on the radar of investors on Wednesday.
Ashwani Gujral of ashwanigujral.com is of the view that one can sell ACC and Aurobindo Pharma and can buy Eicher Motors.
Ashwani Gujral of ashwanigujral.com suggests buying Century Plyboards, Brigade Enterprises, HUDCO, Aurobindo Pharma and Biocon.
The long term trajectory of the market will remain towards an upward trend.
Ashwani Gujral of ashwanigujral.com advises buying Reliance Industries and Aurobindo Pharma on dip.
Aurobindo Pharma gains ahead of US Food and Drug Administration (US FDA) target action date for Renvela generic. In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his readings and outlook on the stock.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
Ashwani Gujral of ashwanigujral.com recommends buying Reliance Industries, Kotak Mahindra Bank and Aurobindo Pharma.
Sandeep Wagle of powermywealth.com recommends buying Chennai Petroleum Corporation and Aurobindo Pharma.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Biocon and Aurobindo Pharma on every dip and advises selling Axis Bank and Adani Ports.
Ashwani Gujral of ashwanigujral.com suggests buying Yes Bank, Indiabulls Housing Finance, Aurobindo Pharma, Capital First and RBL Bank.
According to Prakash Gaba of prakashgaba.com, crucial support to watch would be 9850 and the resistance is at 9916-9969. On the other hand, Bank Nifty has support at 23750 and resistance at 24000-24300.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptualsian.com shared his views and outlook on the fundamentals of the markets and specific stocks.
Ashwani Gujral of ashwanigujral.com recommends buying Tata Global Beverage and Aurobindo Pharma.